Advertisement

Topics

Immuno-Cell Int. Company Profile

00:26 EDT 20th September 2018 | BioPortfolio

Immuno-Cell International © is specialized in the production of printed diagnostic slides and plates, for use in various types of diagnostic test kits. For the Diagnostic Industry (the manufactures of diagnostic test kits) we mostly manufacture these slides and cards custom-made (O.E.M. product). In addition we offer a wide range of standard items, which are available with low minimum order requirements. We supply our slides and cards to the leading test kits manufacturers. The secret of our success is due not only to our high quality product and the service that we povide, but also to the fact that we offer the most complete range of products in the field of diagnostic slides and cards

Location

Hanswijk Ind.Park Motstraat 72/8
Mechelen
B-2800
Belgium

Contact

Phone: 32-15-43.31.88
Fax: 32-15-43.11.21
Email: immuno-cell@immuno-cell.com


News Articles [1546 Associated News Articles listed on BioPortfolio]

Genentech, Affimed Launch Up-to-$5B Cancer Immunotherapy Collaboration

Genentech, a member of the Roche Group, has committed up to $5 billion in potential milestone payments and royalties to Affimed under a collaboration designed to develop and commercialize novel NK cel...

Immuno-Oncology Conference 2018

26 - 27 September, London, UK. Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference will focus on a few key...

$1.6bn ARMO Buy Gives Lilly Its Most Advanced Immuno-Oncology Asset

Eli Lilly & Co. did not rush into the immuno-oncology game like its big pharma peers, but the acquisition of...   

RXi Pharmaceuticals and Karolinska Institutet Collaborate to Advance Immuno-Oncology Therapeutics

NewsThis collaboration will explore RXi's sd-rxRNA compounds against targets involved in T cell and NK cell differentiation.

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the field the Investing News Network (INN) has put together a list of top im...

New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia Therapeutics

CAMBRIDGE, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technolo...

I-O newcomer’s funding now nearly $170 million

TCR2 Therapeutics, an immuno-oncology (I-O) company claiming to be developing a new class of T cell receptor…

Immuno-PCR: A Highly Sensitive Method of Immunodetection

Researchers have relied on immunodetection techniques such as Western blotting, flow cytometry and Enzyme-Linked Immunosorbent Assay (ELISA) for years, but immuno-PCR is a relatively new method. By me...

Drugs and Medications [19 Associated Drugs and Medications listed on BioPortfolio]

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

Alimta [Eli Lilly and Company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyophilized Powder, for ...

Hycamtin [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use HYCAMTIN safely and effectively. See full prescribing information for HYCAMTIN. HYCAMTIN (topotecan) CapsulesInitial U.S. Approval: 19...

Patanol [Physicians Total Care, Inc.]

PubMed Articles [2664 Associated PubMed Articles listed on BioPortfolio]

A microfluidic competitive immuno-aggregation assay for high sensitivity cell secretome detection.

We report a high-sensitivity cell secretome detection method using competitive immuno-aggregation and a micro-Coulter counter. A target cell secretome protein competes with anti-biotin-coated micropar...

Challenges in Immuno-Oncology - Possibilities for Optimization.

Immuno-oncology has undoubtedly started a new era in the treatment of malignant diseases. Within a short time immunotherapeutic therapy concepts have become part of the standard therapy for many tumor...

Demonstration of IgG Subclass (IgG1 and IgG3) in Immuno-Related Hemocytopenia.

Immuno-related hemocytopenia (IRH) is defined as idiopathic cytopenia of undetermined significance (ICUS) patients with autoantibodies. In our previous studies, we found that IgG1 levels were increase...

Targeting the CD73-adenosine axis in immuno-oncology.

The ectonucleotidases CD39 and CD73 are cell surface enzymes that catabolize the breakdown of extracellular ATP into adenosine. As such, they constitute critical components of the extracellular purine...

Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma.

Immuno-oncology therapies represent a new treatment opportunity for patients affected by metastatic melanoma. The purpose of this study was to estimate the costs of immune-related adverse events (irAE...

Clinical Trials [7010 Associated Clinical Trials listed on BioPortfolio]

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

This is a single arm, open-label, uni-center, phase I-II study to evaluate the safety and effectiveness of CAR-T/TCR-T cell immunotherapy in treating with different malignancies patients.

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

The purpose of this study is to find out what effects (good and bad) immunotherapy treatment using the p53 vaccine (Ad.p53-DC) in combination with Nivolumab and Ipilimumab has on small cel...

Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma

Multi-center, prospective randomised phase III study evaluating capecitabine in combination with standard-immunotherapy versus standard-immunotherapy alone as first-line therapy in patient...

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer ...

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with GD2 positive glioma patients.

Companies [1043 Associated Companies listed on BioPortfolio]

Immuno-Cell Int.

Immuno-Cell International © is specialized in the production of printed diagnostic slides and plates, for use in various types of diagnostic test kits. For the Diagnostic Industry (the manufactures o...

Immuno-Cell

Manufacture of slides and cards for use in test kits.

NantCell, Inc.

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by de...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

Immuno Diagnostic Oy

Immuno Diagnostic Oy was established in 1983. Thus, we have a long experience in importing and marketing high quality reagents for diagnostics and research. We provide our customers with a wide range ...

More Information about "Immuno-Cell Int." on BioPortfolio

We have published hundreds of Immuno-Cell Int. news stories on BioPortfolio along with dozens of Immuno-Cell Int. Clinical Trials and PubMed Articles about Immuno-Cell Int. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno-Cell Int. Companies in our database. You can also find out about relevant Immuno-Cell Int. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record